Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 5, 2005, Pages 1058-1063

  Kattan, Meyer ^a   Stearns, Sally C ^b   Crain, Ellen F ^c   Stout, James W ^d   Gergen, Peter J ^e   Evans III, Richard ^f   Visness, Cynthia M ^g   Gruchalla, Rebecca S ^h   Morgan, Wayne J ⁱ   O'Connor, George T ^j   Mastin, J Patrick ^k   Mitchell, Herman E ^g  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g RHO INC   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

more..

Author keywords

Allergen mitigation; Asthma; Asthma intervention; Cost effectiveness; Inner city

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; STEROID;

ALLERGIC ASTHMA; AMBIENT AIR; ARTICLE; CHILD; CITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ENVIRONMENTAL SANITATION; FOLLOW UP; HEALTH CARE COST; HEALTH SERVICE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INDOOR AIR POLLUTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AIR POLLUTION, INDOOR; ASTHMA; CHILD; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; POVERTY AREAS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; URBAN POPULATION;

EID: 27644596223     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.07.032     Document Type: Article

References (14)

1. P.W. Newacheck, and N. Halfon Prevalence, impact, and trends in childhood disability due to asthma Arch Pediatr Adolesc Med 154 2000 287 293
2. M. Kattan, H. Mitchell, P. Eggleston, P. Gergen, E. Crain, and S. Redline Characteristics of inner-city children with asthma: the National Cooperative Inner-City Asthma Study Pediatr Pulmonol 24 1997 253 262
3. D.L. Rosenstreich, P. Eggleston, M. Kattan, D. Baker, R.G. Slavin, and P. Gergen The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma N Engl J Med 336 1997 1356 1363
4. W.J. Morgan, E.F. Crain, R.S. Gruchalla, G.T. O'Connor, M. Kattan, and R. Evans 3rd Results of a home-based environmental intervention among urban children with asthma N Engl J Med 351 2004 1068 1080
5. E.F. Crain, M. Walter, G.T. O'Connor, H. Mitchell, R.S. Gruchalla, and M. Kattan Home and allergic characteristics of children with asthma in seven U.S. urban communities and design of an environmental intervention: the Inner-City Asthma Study Environ Health Perspect 110 2002 939 945
6. S.D. Sullivan, K.B. Weiss, H. Lynn, H. Mitchell, M. Kattan, and P.J. Gergen The cost-effectiveness of an inner-city asthma intervention for children J Allergy Clin Immunol 110 2002 576 581
7. M.A. Chaudhary, and S.C. Stearns Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial Stat Med 15 1996 1447 1458
8. L.Y. Wang, Y. Zhong, and L. Wheeler Direct and indirect costs of asthma in school-age children Prev Chronic Dis 2 2005 A11
9. M.D. Krahn, C. Berka, P. Langlois, and A.S. Detsky Direct and indirect costs of asthma in Canada, 1990 CMAJ 154 1996 821 831
10. K.B. Weiss, P.J. Gergen, and T.A. Hodgson An economic evaluation of asthma in the United States N Engl J Med 326 1992 862 866
11. K.B. Weiss, S.D. Sullivan, and C.S. Lyttle Trends in the cost of illness for asthma in the United States, 1985-1994 J Allergy Clin Immunol 106 2000 493 499
12. R.E. Stein, S.L. Gortmaker, E.C. Perrin, J.M. Perrin, I.B. Pless, and D.K. Walker Severity of illness: concepts and measurements Lancet 2 1987 1506 1509
13. A.D. Paltiel, A.L. Fuhlbrigge, B.T. Kitch, B. Liljas, S.T. Weiss, and P.J. Neumann Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model J Allergy Clin Immunol 108 2001 39 46
14. S.D. Sullivan, M. Buxton, L.F. Andersson, C.J. Lamm, B. Liljas, and Y.Z. Chen Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma J Allergy Clin Immunol 112 2003 1229 1236